Free
Correspondence  |   August 2017
In Reply
Author Notes
  • Peking University First Hospital, Beijing, China (D.-X.W.). wangdongxin@hotmail.com
  • (Accepted for publication May 8, 2017.)
    (Accepted for publication May 8, 2017.)×
Article Information
Correspondence
Correspondence   |   August 2017
In Reply
Anesthesiology 8 2017, Vol.127, 398-399. doi:10.1097/ALN.0000000000001723
Anesthesiology 8 2017, Vol.127, 398-399. doi:10.1097/ALN.0000000000001723
We agree with Dr. Goucher et al. that low-dose dexmedetomidine infusion did not restore the normal sleep architecture because stage 3 non–rapid eye movement sleep and rapid eye movement (REM) sleep remained significantly decreased or absent in our patients.1  This is also the case when dexmedetomidine was administered for sedation in mechanically ventilated patients.2,3  It should be noted that the target subjects were patients in the intensive care unit (ICU) after major surgery in our study1  or receiving mechanical ventilation in another previous study.3  It is well known that significant sleep disturbances such as fragmented sleep, decreased sleep efficiency, increased stage 1 non-REM sleep, and decreased or absent stage 3 non-REM and REM sleep are often present in those patients. Dexmedetomidine partially improved “sleep architecture” through increasing the percentage of stage 2 non-REM sleep (and decreasing the percentage of stage 1 non-REM sleep), a unique property that has also been demonstrated in other clinical studies previously.4 
Considering the importance of sleep for ICU recovery and the lack of effective pharmacologic interventions to improve sleep,5  prophylactic low-dose dexmedetomidine may be a choice, although not the best. Clinical effectiveness was demonstrated in our previous trial in 700 patients admitted to the ICU after noncardiac surgery, in which low-dose dexmedetomidine infusion reduced the incidence of delirium during the first 7 days after surgery (9% compared with 23% with placebo) and also decreased the incidence of nondelirium complications and increased early hospital discharge.6  We cannot establish a causal relationship between delirium reduction and improved sleep in patients from these two independent trials.1,6 
It is true that hemodynamic disturbances are major concerns when using dexmedetomidine in ICU patients. Indeed, dexmedetomidine at such a low dose (0.1 µg kg−1 h−1) slightly increased the occurrence of hypotension, although not statistically significantly,6  indicating that close monitoring is necessary whenever dexmedetomidine is on-board. Last but not least, whether delirium prevention by dexmedetomidine ultimately improves patients’ long-term outcome remains unknown and warrants further study.
Regarding the question of Dr. Reade, herein we confirm that these two studies1,6  are completely independent trials in which each has an individual registration (Chinese Clinical Trial Registry [Chengdu, Sichuan, China; www.chictr.org.cn] Nos. ChiCTR-TRC-10000802 and ChiCTR-TRC-12002567). Patients who were recruited in one study were not enrolled the other one.
Research Support
Support provided by Wu Jieping Medical Foundation (Beijing, China). Study drugs were manufactured and supplied by Jiangsu Hengrui Medicine Co., Ltd. (Jiangsu, China). The sponsors have no role in the study design and conduct; the collection, management, analysis, and interpretation of the data; or the preparation and approval of the manuscript.
Competing Interests
Dr. Wang reports that he has received lecture fees and travel expenses for lectures given at domestic academic meetings from Jiangsu Hengrui Medicine Co., Ltd. (Jiangsu, China). The other author reports no competing interests.
Dong-Xin Wang, M.D., Ph.D., Daqing Ma, M.D., Ph.D., F.R.C.A. Peking University First Hospital, Beijing, China (D.-X.W.). wangdongxin@hotmail.com
References
Wu, XH, Cui, F, Zhang, C, Meng, ZT, Wang, DX, Ma, J, Wang, GF, Zhu, SN, Ma, D : Low-dose dexmedetomidine improves sleep quality pattern in elderly patients after noncardiac surgery in the intensive care unit: A pilot randomized controlled trial. Anesthesiology 2016; 125:979–91 [Article] [PubMed]
Oto, J, Yamamoto, K, Koike, S, Onodera, M, Imanaka, H, Nishimura, M : Sleep quality of mechanically ventilated patients sedated with dexmedetomidine. Intensive Care Med 2012; 38:1982–9 [Article] [PubMed]
Alexopoulou, C, Kondili, E, Diamantaki, E, Psarologakis, C, Kokkini, S, Bolaki, M, Georgopoulos, D : Effects of dexmedetomidine on sleep quality in critically ill patients: A pilot study. Anesthesiology 2014; 121:801–7 [Article] [PubMed]
Huupponen, E, Maksimow, A, Lapinlampi, P, Särkelä, M, Saastamoinen, A, Snapir, A, Scheinin, H, Scheinin, M, Meriläinen, P, Himanen, SL, Jääskeläinen, S : Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiol Scand 2008; 52:289–94 [Article] [PubMed]
Kanji, S, Mera, A, Hutton, B, Burry, L, Rosenberg, E, MacDonald, E, Luks, V : Pharmacological interventions to improve sleep in hospitalised adults: A systematic review. BMJ Open 2016; 6:e012108 [Article] [PubMed]
Su, X, Meng, ZT, Wu, XH, Cui, F, Li, HL, Wang, DX, Zhu, X, Zhu, SN, Maze, M, Ma, D : Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: A randomised, double-blind, placebo-controlled trial. Lancet 2016; 388:1893–902 [Article] [PubMed]